orthotw.com /3 weeks ago

Best New Pain Management Technologies for 2026

This year’s Pain Management Technology Awards winners take on pain from three directions: a stimulation electrode placed through a needle, a disposable kit for decompressing the lu...

Read source
orthotw.com /1 month ago

TLC590 Achieves Statistically Significant Reductions in Pain and Opioid Use Versus Both Placebo and Liposomal Bupivacain...

TLC BioSciences Corp. today announced positive topline results from its pivotal Phase 3 trial of TLC590.

Read source
orthotw.com /1 month ago

Consano Bio to Highlight C-1101, Its Potential First-in-Class Disease-Modifying Therapeutic for Chronic Sciatica, at Upc...

Read source
orthotw.com /1 month ago

Johnson & Johnson announces TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to show significant improvem...

Topline results show TREMFYA met the primary and major secondary endpoints of axial involvement in PsA - including spinal pain and stiffness...

Read source
orthotw.com /4 weeks ago

Dr. Kenneth Pettine, CEO of Direct Regeneration, Unveils Breakthrough Regenerative Technologies Set to Disrupt Orthopedi...

Dr. Kenneth Pettine, CEO of Direct Regeneration, announced a landmark portfolio of technologies poised to revolutionize the treatment of osteoarthritis, chronic pain...

Read source
orthotw.com /1 month ago

Putting Pain on Ice: FDA Opens a New Chapter in Injectable Nerve Treatment

A truly novel treatment for pain associated with knee osteoarthritis was just granted its own, entirely new 510(k) device category.

Read source
orthospinenews.com /1 week ago

OrthoTrophix Presents Data on TPX-100, Meniscal Pathology and Structural Progression in Knee Osteoarthritis

FOSTER CITY, Calif., Nov. 9, 2026 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced data from two…

Read source
newswire.com /1 month ago

PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial o...

Companies to use AI-enabled digital pathology and spatial single-fiber analysis to characterize the mechanistic effects of MTX-474 in systemic sclerosis

Read source
healio.com /3 weeks ago

Retatrutide reduces osteoarthritis pain in patients with obesity

Treatment with retatrutide significantly reduced knee osteoarthritis pain and body weight among adults with obesity without diabetes, according to results published in The New Engl...

Read source
orthotw.com /1 month ago

Consano Bio Raises More Than $15 Million in Oversubscribed Financing to Advance C-1101 in Chronic Painful Lumbosacral Ra...

Proceeds will fund completion of the Phase 1 trial and continued development of C-1101, a potential first-in-class disease-modifying therapeutic -- Clinical data expected in 1H 202...

Read source
healio.com /2 weeks ago

Reneurx nerve-selective therapy may reduce pain for knee OA

DALLAS — Results showed Reneurx nerve-selective therapy may be safe and effective for pain associated with knee osteoarthritis with better pain reduction and functional outcomes co...

Read source
painnewsnetwork.org /1 month ago

Wearable Device Predicts Migraines With Over 90% Accuracy

By Pat AnsonImagine what it would be like to know – with over 90% accuracy – that you’re going to have a migraine tomorrow.You’d be able to plan ahead. Change your schedule. Get ex...

Read source
healio.com /1 week ago

Weight loss with retatrutide signals ‘new days’ in osteoarthritis

ORLANDO — Weekly injections of the GLP-1 receptor agonist retatrutide improved knee osteoarthritis pain in addition to inducing weight loss, according to data presented at ACR Conv...

Read source
prweb.com /1 month ago

Materna Medical Announces New Benchmark for Measuring Meaningful Improvement in Vaginismus

Study data presented at The Menopause Society 2026 Annual Meeting give researchers and clinicians a shared way to tell whether a treatment truly helps women with painful penetratio...

Read source
newswire.com /4 weeks ago

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network

Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim...

Read source
orthotw.com /1 month ago

Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Assoc...

Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the publication of a milestone study.

Read source
newswire.com /1 month ago

BODYWELLE Announces Exclusive Use of ZEO ScientifiX Biologics for Pain, Joints, and Wound Care Treatments

The Miami Beach practice now uses quantified stem cell and extracellular vesicle products, along with an autologous option derived from the patient's own platelets.

Read source
newswire.com /2 weeks ago

DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee

Corexa Pharmacy to dispense compounded BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax in accordance with HHS' recently updated Enforcement Discretion PolicyBulk drug substance ac...

Read source
orthotw.com /1 month ago

ModMed Launches New ModMed AI Analytics at MOMENTUM 2026

Specialty medical practices can access new AI chat tools, conversational analytics, and automated report delivery inside their daily workflow

Read source
orthotw.com /1 month ago

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and Unite...

Pacira BioSciences today announced a strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets.

Read source
healio.com /1 week ago

OSCA stem cell therapy imparts osteoarthritis structural changes

ORLANDO — A single-injection combination of osiramestrocel and an acellular cartilage matrix improved pain and triggered favorable structural changes in knee osteoarthritis, accord...

Read source
orthotw.com /1 month ago

FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity

Chronic lower back pain is one of the most common and costly medical conditions, and degeneration of the intervertebral discs is a frequent underlying cause.

Read source
painnewsnetwork.org /1 month ago

Clinical Trials Begin in U.S. for First Cannabis-Based Medicine for Chronic Pain 

By Pat AnsonThe first clinical trials in the United States for a cannabis-based medicine for chronic pain are getting underway.New York State has authorized a clinical trial of VER...

Read source
seekingalpha.com /2 weeks ago

Rhythm expects to dose first Phase III bivamelagon HO patients in January as it commits to $350M royalty buy-down

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.